Test Price
600 AEDโ Home Collection Available
๐ Results in 7โ10 Business Days
BCR-ABL Gene Rearrangement Qualitative PCR Test in UAE | 600 AED | DHA Licensed
Executive Summary & Core Metrics
99.9% Diagnostic Sensitivity through ISO 15189-accredited processing at DNA Labs UAE. This diagnostic test requires a hospital-based extraction procedure. Complimentary post-test telephonic clinical guidance is provided by our Consultant Medical Geneticist. Direct insurance billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This highly sensitive molecular test detects the BCR-ABL1 fusion gene characteristic of chronic myeloid leukemia (CML) and certain acute leukemias, providing a definitive yes/no result for the presence of the Philadelphia chromosome translocation at initial diagnosis.
| Feature | Our BCR-ABL Qualitative PCR | Closest Alternative (Quantitative PCR / FISH) |
|---|---|---|
| Diagnostic Precision | 99.9% sensitivity with dual-probe RT-qPCR | Sensitivity 95-98%; potential for false negatives in low-level disease |
| Methodology | Reverse Transcription Real-Time PCR (RT-qPCR) + digital PCR confirmation upon request | Quantitative RT-PCR (reports transcript ratios) / FISH (limited by probe binding) |
| Turnaround Time | 7โ10 Business Days | Often 3โ5 working days, depending on lab load |
Physician Insight & Safety Protocols
A note from Consultant Medical Geneticist Lina Osama Zaki Quteineh (DHA ID: 9294403):
As a DHA-licensed Consultant Medical Geneticist specializing in molecular hematology, I emphasize that while this qualitative PCR test is a cornerstone for initial diagnosis of Philadelphia-chromosome positive leukemias, its result must be interpreted in the full context of clinical presentation, complete blood count, and bone marrow morphology. A negative result does not entirely rule out other molecular subtypes, and a positive result should be confirmed with quantitative monitoring and mutational analysis. Patient-physician communication is key to understanding the treatment pathway and avoiding anxiety.
Medication & Treatment Advisory
Do not discontinue or modify any prescribed chemotherapy, targeted agents (e.g., imatinib, dasatinib), or supportive medications without consulting your treating oncologist. The BCR-ABL qualitative test is a diagnostic aid and does not replace clinical judgment or ongoing monitoring.
Safety & Exclusion Criteria for Hospital Extraction
Hospital Extraction Only โ Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
- Exclusion for bone marrow aspiration: active bleeding diathesis, haemodynamic instability (requires prior stabilisation).
- ER Red Flags: sudden high fever, severe bone pain, or uncontrolled bleeding after sample collection โ proceed to the nearest emergency department immediately.
- Our hospital-based phlebotomy team is trained to recognise and escalate acute symptoms during collection.
Patient FAQ & Clinical Guidance
1. What does a positive BCR-ABL qualitative PCR result mean?
A positive result confirms the presence of the BCR-ABL1 fusion gene associated with Philadelphia chromosome-positive leukemias. This finding typically indicates chronic myeloid leukaemia (CML) or a subset of acute lymphoblastic leukaemia (ALL). Further quantitative testing is needed to assess disease burden and monitor therapy.
2. How should I prepare for the BCR-ABL qualitative test?
No fasting or special preparation is required; the sample must be collected in an EDTA tube and transported refrigerated, not frozen. Our hospital logistics team handles all pre-analytical transportation to maintain cold-chain integrity. Schedule your hospital appointment and avoid strenuous exercise immediately before the extraction.
3. How accurate is this qualitative PCR compared to a bone marrow biopsy?
Our qualitative PCR offers 99.9% diagnostic sensitivity, surpassing morphological assessment in detecting minimal leukemic clones. While a bone marrow biopsy provides cellular architecture, PCR detects the BCR-ABL1 transcript at a molecular level, identifying residual disease that may be invisible under a microscope. Both tests are complementary and often used together at diagnosis.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under DHA Facility License Number 1143, strictly adhering to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient data is encrypted, access-controlled, and processed solely for clinical diagnostic purposes. Our laboratory protocols comply with Federal Decree-Law No. 4 of 2016 on Medical Liability to ensure patient safety and clinical excellence.
Clinical & Logistical Metadata
| Test Name | BCR-ABL Gene Rearrangement Qualitative PCR |
| Price (AED) | 600 AED |
| Turnaround Time | 7โ10 Business Days |
| Sample Type / Matrix | Whole Blood (EDTA) or Bone Marrow Aspirate (Hospital Extraction Only) |
| Methodology Used | Reverse Transcription Real-Time PCR (RT-qPCR) with p190/p210 probe sets; digital PCR confirmation available upon request. |
| ICD-10-CM Code | C92.10, C91.00, C92.00 |
| LOINC Code | 55990-1 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
Preparation Required
["No fasting required", "Sample must be collected in an EDTA tube", "Sample must be transported refrigerated"]
Medically Reviewed by Dr. Lina Osama Zaki Quteineh
All content reviewed by qualified professionals for accuracy.
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians